NCT01445483: Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases

NCT01445483
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER++, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years to 90 Years (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: 
Exclusions: Patients treated for a previous brain metastasis; Patients who received cranial radiation
https://ClinicalTrials.gov/show/NCT01445483

Comments are closed.

Up ↑